Richard Childress Racing Retires No 8 in Kyle Buschs Honor With Son Brexton Poised to Revive It Perpetua Resources Secures 29 Billion US Loan for Idaho GoldAntimony Project Amid Critical Minerals Push Vijay Kedia Calls for Abolition of LongTerm Capital Gains Tax Citing Patient Capital for Nation Building Nvidias Earnings Reveal a 200 Billion Opportunity and Edge Computing Push Despite China Concession Oil Prices Decline Amid Renewed Prospects for USIran Nuclear Agreement Market Bubble Risks Key Factors That Could Trigger a Correction M Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher AORT Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter GXAI Q1 2026 Earnings EPS Misses Estimates No Revenue Reported BCDA Q1 2026 Earnings WiderThanExpected Loss Amid No Revenue Stock Rises 329 FENC Q1 2026 Earnings Unexpected Profitability Surprises Market Stock Edges Lower VIVS Q3 2025 Earnings EPS Beat on Cost Management Amidst Ongoing Development Sprott Focus Trust Inc FUND Edges Higher as Precious Metals Fund Holds Near Key Support Cognition Therapeutics CGTX Slides 159 as Biotech Sector Headwinds Persist DigitalOcean Holdings DOCN Advances Modestly as Cloud Platform Momentum Persists abrdn Global Premier Properties Fund AWP Edges Higher Amid Steady Support Levels Toyota Motor TM Holds Near Resistance Amid Modest Gains SLNG Q1 2026 Earnings Heavy EPS Miss Amidst Operational Headwinds IDN Q1 2026 Earnings EPS Surges Past Estimates Stock Dips Despite Strong Beat Omega Healthcare Investors Inc OHI Q1 2026 Earnings Solid EPS Beat Fails to Lift Stock Park Dental Partners Inc PARK Q1 2026 Earnings EPS Smashes Estimates Stock Gains on Strong Operational Performance Local Bounti Q1 2026 Earnings EPS Beats Estimate Stock Declines on Limited Disclosure OXSQG Q1 2026 Earnings EPS Misses Estimates as Notes Decline BlackRocks IBIT Records 13 Billion Dark Pool Trade Amid Broader Bitcoin ETF Outflows Owens Corning Inc OC Q1 2026 Earnings Strong EPS Surprise Lifts Shares as Management Highlights Operational Discipline Filana Therapeutics FLNA Gains 638 as Biotech Momentum Builds